(RX) Biosyent - Performance 26.5% in 12m
Compare RX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
80.30%
#4 in Group
Rel. Strength
81.93%
#1444 in Universe
Total Return 12m
26.45%
#26 in Group
Total Return 5y
175.68%
#11 in Group
P/E 16.1
30th Percentile in Group
P/E Forward 12.4
42th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield 4.31%
64th Percentile in Group
12m Total Return: RX (26.5%) vs XLV (-0.5%)
5y Drawdown (Underwater) Chart
Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
10.2% | 175% | 405% | 55.8 | 41 | 0.61 | 61.4% | 10.7% |
| LLY NYSE Eli Lilly |
2.12% | 13.3% | 466% | 62.7 | 31.5 | 1.05 | 40.3% | 34.5% |
| NVS NYSE Novartis |
-1.21% | 24.1% | 59.8% | 18 | 12.9 | 1.23 | 36.2% | 11% |
| SFZN SW Siegfried Holding |
-2.09% | 1.78% | 95.3% | 24.1 | 22.1 | 1.41 | 66.7% | 72.5% |
| SUPN NASDAQ Supernus Pharmaceuticals |
-4.71% | 6.55% | 74.3% | 24 | 20.2 | 1.47 | -20.8% | -17% |
| SOBI ST Swedish Orphan Biovitrum |
-8.43% | 1.39% | 42.8% | 23.3 | 18.7 | 1.44 | 11.8% | 14.7% |
| SAN PA Sanofi |
-15.7% | 10.9% | 24.2% | 21.9 | 11.6 | 0.93 | -22.1% | -24.8% |
| NOVN SW Novartis |
-7.92% | 11.1% | 33.1% | 17.9 | 12.8 | 1.22 | 36.2% | 11.2% |
Performance Comparison: RX vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for RX
| Total Return (including Dividends) | RX | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -6.67% | -7.37% | -5.89% |
| 3 Months | -2.70% | -4.55% | -12.45% |
| 12 Months | 26.45% | -0.54% | 6.72% |
| 5 Years | 175.68% | 46.59% | 101.06% |
| Trend Score (consistency of price movement) | RX | XLV | S&P 500 |
| 1 Month | -78.3% | -82.6% | -74.5% |
| 3 Months | -21.4% | -37.8% | -88.2% |
| 12 Months | 75.0% | -1.6% | 66.1% |
| 5 Years | 78.2% | 90.1% | 84.3% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #68 | 0.76% | -0.83% |
| 3 Month | #50 | 1.94% | 11.1% |
| 12 Month | #27 | 27.1% | 18.5% |
| 5 Years | #11 | 88.1% | 37.1% |
FAQs
Does RX Biosyent outperforms the market?
Yes,
over the last 12 months RX made 26.45%, while its related Sector, the Health Care Sector SPDR (XLV) made -0.54%.
Over the last 3 months RX made -2.70%, while XLV made -4.55%.
Over the last 3 months RX made -2.70%, while XLV made -4.55%.
Performance Comparison RX vs Indeces and Sectors
RX vs. Indices RX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 2.76% | -0.78% | 7.79% | 19.7% |
| US NASDAQ 100 | QQQ | 3.62% | -0.39% | 8.32% | 20.9% |
| US Dow Jones Industrial 30 | DIA | 3.93% | -0.85% | 7.25% | 21.1% |
| German DAX 40 | DAX | -2.60% | 2.73% | -9.27% | 8.24% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 2.05% | 0.83% | 5.51% | 20.6% |
| Hongkong Hang Seng | HSI | -1.53% | 3.15% | 6.27% | 10.2% |
| India NIFTY 50 | INDA | -1.61% | -11.4% | 5.34% | 23.4% |
| Brasil Bovespa | EWZ | -0.80% | -1.59% | 4.84% | 35.9% |
RX vs. Sectors RX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 2.51% | -1.01% | -1.02% | 12.9% |
| Consumer Discretionary | XLY | 3.63% | -2.75% | 5.05% | 17.2% |
| Consumer Staples | XLP | -0.54% | -9.87% | -2.43% | 12.5% |
| Energy | XLE | -1.96% | 3.41% | 6.73% | 36.7% |
| Financial | XLF | 1.39% | -2.16% | -0.33% | 7.50% |
| Health Care | XLV | 2.36% | 0.70% | 9.19% | 27.0% |
| Industrial | XLI | 1.64% | -1.97% | 7.71% | 21.1% |
| Materials | XLB | 1.04% | -0.02% | 14.9% | 34.0% |
| Real Estate | XLRE | -2.58% | -3.78% | 6.44% | 9.34% |
| Technology | XLK | 4.12% | 2.26% | 14.6% | 27.7% |
| Utilities | XLU | -0.55% | -6.25% | 2.05% | 2.08% |
| Aerospace & Defense | XAR | 1.07% | -6.71% | -1.97% | 2.29% |
| Biotech | XBI | -0.80% | 5.21% | 22.3% | 35.4% |
| Homebuilder | XHB | 1.81% | 0.17% | 25.7% | 35.6% |
| Retail | XRT | 1.06% | -4.56% | 12.5% | 30.8% |